Evidence map›Paper›PMID 35051005›Full record

ArticleToxins2022

Mycotoxin Interactions along the Gastrointestinal Tract: In Vitro Semi-Dynamic Digestion and Static Colonic Fermentation of a Contaminated Meal.

Maria Madalena Costa Sobral, Tiago Gonçalves, Zita E Martins, Christine Bäuerl, Erika Cortés-Macías, Maria Carmen Collado, Isabel M P L V O Ferreira

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. The intestinal microbiota as mediators between dietary contaminants and host health.Experimental biology and medicine (Maywood, N.J.) · 2023
    Review
  11. Article
  12. Total Flavonoids ofAntioxidants (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Maria Madalena Costa SobralLAQV/REQUIMTE-Laboratório de Bromatologia e Hidrologia, Faculdade de Farmácia da Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-5747-2370
Tiago GonçalvesLAQV/REQUIMTE-Laboratório de Bromatologia e Hidrologia, Faculdade de Farmácia da Universidade do Porto, 4050-313 Porto, Portugal.
Zita E MartinsLAQV/REQUIMTE-Laboratório de Bromatologia e Hidrologia, Faculdade de Farmácia da Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-1024-4792
Christine BäuerlIATA-CSIC-Institute of Agrochemistry and Food Science-National Research Council, Agustín Escardino 7, 46980 Valencia, Spain.
Erika Cortés-MacíasIATA-CSIC-Institute of Agrochemistry and Food Science-National Research Council, Agustín Escardino 7, 46980 Valencia, Spain.
Maria Carmen ColladoIATA-CSIC-Institute of Agrochemistry and Food Science-National Research Council, Agustín Escardino 7, 46980 Valencia, Spain.ORCID 0000-0002-6204-4864
Isabel M P L V O FerreiraLAQV/REQUIMTE-Laboratório de Bromatologia e Hidrologia, Faculdade de Farmácia da Universidade do Porto, 4050-313 Porto, Portugal.
Universidade do Porto · PTInstituto de Agroquímica y Tecnología de Alimentos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aflatoxin B1 (AFB1) and ochratoxin A (OTA) naturally co-occur in several foods, but no studies have followed the fate of mycotoxins' interactions along the gastrointestinal tract using in vitro digestion models. This study used a novel semi-dynamic model that mimics gradual acidification and gastric emptying, coupled with a static colonic fermentation phase, in order to monitor mycotoxins' bioaccessibility by the oral route. AFB1 and OTA bioaccessibility patterns differed in single or co-exposed scenarios. When co-exposed (MIX meal), AFB1 bioaccessibility at the intestinal level increased by ~16%, while OTA bioaccessibility decreased by ~20%. Additionally, a significant increase was observed in both intestinal cell viability and NO production. With regard to mycotoxin-probiotic interactions, the MIX meal showed a null effect on

Indexed as

Food ContaminationAflatoxin B1ColonDigestionFermentationGastrointestinal MicrobiomeGastrointestinal TractMycotoxinsOchratoxinsPoisonsPortugalAflatoxin B1MycotoxinsOchratoxinsPoisonsaflatoxin B1gut microbiotainflammationin vitro modelsochratoxin A

Identifiers

PMID35051005
PMCPMC8779761
OpenAlexW4205870810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.